Nasal Blockage
Difficulty breathing through the nose due to congestion or swelling within the nasal passages.
Recurring sinus problems can affect breathing, sleep and everyday comfort. Nasal congestion, facial pressure and repeated episodes of sinusitis may indicate ongoing inflammation within the sinus passages.
EverOpen+, developed by Dr. Muaaz Tarabichi, combines endoscopic sinus surgery with a dissolvable, drug-releasing implant designed to manage inflammation after the procedure.
This approach aims to maintain improved sinus drainage and help reduce the likelihood of blockage returning.
Chronic sinusitis, also called chronic rhinosinusitis, involves inflammation of the nose and sinus lining that continues for 12 weeks or longer.
As the tissues become swollen, normal mucus drainage may be affected. This can lead to nasal blockage, pressure around the face, mucus buildup and changes in the sense of smell.
Some individuals experience symptoms that continue despite medical treatment or return after previous episodes of sinusitis.
An ENT specialist can evaluate the affected sinus pathways and recommend treatment based on the underlying condition.
Sinus inflammation can affect daily comfort and may require further evaluation when symptoms continue or repeatedly return.
Difficulty breathing through the nose due to congestion or swelling within the nasal passages.
Repeated episodes of sinus discomfort, congestion or inflammation.
Pressure or discomfort around the forehead, cheeks, eyes or nose.
Thick mucus, nasal drainage or mucus moving down the back of the throat.
Changes in the ability to detect or recognize everyday smells.
Sinus concerns that continue or return following medication or previous treatment.
Sinus treatment is determined by the underlying condition, symptom history, examination findings and previous treatment response.
Medical management may be used to address sinus inflammation and associated symptoms.
Depending on the condition, treatment may include:
Endoscopic sinus surgery is an approach used to treat affected sinus drainage pathways when surgical treatment is appropriate.
The procedure is performed through the nostrils using an endoscope and specialized instruments.
Treatment objectives may include:
EverOpen+ is an advanced sinus surgery approach developed by Dr. Muaaz Tarabichi for patients with chronic or recurring sinusitis.
It brings together two important components: endoscopic treatment of affected sinus drainage pathways and a dissolvable implant that releases anti-inflammatory medication directly into the operated area.
Following sinus surgery, inflammation and swelling can narrow the treated drainage passages.
The EverOpen+ implant delivers medication at the surgical site during recovery, helping manage this swelling and maintain the improvements achieved through surgery.
The temporary implant gradually dissolves in approximately 45β60 days.
By addressing drainage and postoperative inflammation together, EverOpen+ helps to reduce the likelihood of sinus blockage returning compared with traditional sinus surgery alone.
The EverOpen+ treatment process combines individual ENT assessment with surgical care, anti-inflammatory implant technology and postoperative follow-up.
An ENT specialist reviews your symptoms, medical history, previous treatments and examination findings.
The specialist evaluates the affected sinus pathways and determines an appropriate treatment plan based on your clinical condition.
Endoscopic sinus surgery improves the affected drainage pathways. A dissolvable drug-releasing implant is placed within the treated area to deliver anti-inflammatory medication during recovery.
The implant gradually dissolves in approximately 45β60 days. Your treating specialist provides medication guidance, postoperative instructions and follow-up care.
Postoperative care plays an important role in maintaining the improvements achieved through endoscopic sinus surgery.
EverOpen+ incorporates anti-inflammatory medication delivery to help control swelling during the recovery period, when the treated sinus passages are healing.
The purpose of combining surgery with anti-inflammatory implant technology is to address factors that can contribute to renewed sinus blockage during recovery.
The drug-releasing implant delivers medication to the operated sinus area to help reduce swelling.
The temporary implant dissolves naturally in approximately 45β60 days.
Review appointments allow the treating specialist to monitor recovery and assess the condition of the sinus passages.
Medication, nasal irrigation and other recovery instructions are provided according to the patient's treatment needs.
Dr. Muaaz Tarabichi is an ENT specialist with experience in endoscopic surgical techniques, sinus care and specialist medical education.
He developed EverOpen+ to combine endoscopic treatment of affected sinus pathways with drug-releasing implant technology that addresses postoperative inflammation.
His professional activities include involvement with the Tarabichi Stammberger Ear and Sinus Institute (TSESI) and the Sinus Link Network.
Chronic sinusitis is inflammation of the nose and sinus lining lasting 12 weeks or longer. Common symptoms include nasal blockage, facial pressure, mucus buildup and reduced sense of smell.
Ongoing inflammation can cause swelling that affects normal sinus drainage. An ENT evaluation helps identify the underlying factors contributing to repeated symptoms.
Treatment options include medical management and, when clinically appropriate, endoscopic sinus surgery. The recommended approach depends on the patient's condition and examination findings.
EverOpen+ combines endoscopic sinus surgery with a dissolvable drug-releasing implant. The approach aims to improve affected sinus drainage pathways while managing inflammation during postoperative recovery.
EverOpen+ addresses affected drainage pathways through endoscopic surgery while the implant releases anti-inflammatory medication at the treatment site. This combined approach may reduce the likelihood of renewed blockage compared with surgery alone.
The implant gradually delivers anti-inflammatory medication directly into the treated sinus area, helping reduce swelling during recovery.
The implant gradually dissolves in approximately 45β60 days and is not intended to remain permanently.
Recovery varies according to the procedure and individual healing response. Your ENT specialist provides instructions regarding medication, postoperative care and follow-up appointments.
EverOpen+ may be considered for patients with chronic or recurring sinusitis following a specialist evaluation. Treatment suitability is based on symptoms, previous care and clinical findings.
You can submit an enquiry through the Resolved Sinus consultation form. The patient coordination team can provide information about appointment arrangements and available next steps.
Experiencing persistent or recurring sinus symptoms? Learn more about EverOpen+ Advanced Sinus Surgery and available ENT consultation options in Abu Dhabi.
Enquire about EverOpen+, participating ENT specialists and consultation availability.
Contact our team for assistance with consultation enquiries and treatment information.
NMC Royal Hospital, Abu Dhabi, UAE.
Complete the form below and our team can contact you regarding available consultation options.
Persistent sinus congestion, facial pressure, reduced sense of smell, or recurring sinus infections can interfere with everyday life.
EverOpen+ is an advanced sinus surgery approach developed by Dr. Muaaz Tarabichi, focusing on both surgical treatment and postoperative healing.
For selected patients with chronic sinusitis who continue experiencing symptoms despite appropriate medical treatment, endoscopic sinus surgery may help improve sinus drainage and relieve symptoms. The EverOpen+ approach also emphasizes postoperative inflammation management, including drug-releasing sinus implants when clinically appropriate.
Explore your treatment options and learn whether advanced sinus surgery may be suitable for you.
Advanced sinus treatment aims to manage persistent symptoms, improve sinus drainage, and support a better quality of life for selected patients.
When appropriate medical treatment has not provided sufficient relief, endoscopic sinus surgery may be considered. EverOpen+ focuses on both the surgical procedure and postoperative healing, including inflammation management during recovery.
Treatment benefits vary according to the underlying sinus condition, previous treatment history, and individual clinical needs.
For suitable patients, drug-releasing sinus implants may be used after endoscopic sinus surgery to deliver anti-inflammatory medication locally and support the healing process.
Endoscopic sinus surgery aims to improve symptoms such as nasal blockage, facial pressure, and reduced sense of smell in appropriately selected patients.
Managing chronic sinusitis may require ongoing treatment even after surgery. The EverOpen+ approach emphasizes postoperative care, healing, and continued management of sinus inflammation.
Locate expert practitioners trained in our EverOpen+ sinus surgery technique, designed to improve long-term sinus health and reduce the need for multiple procedures.
Chronic sinusitis occurs when inflammation of the nose and sinuses persists for 12 weeks or longer, together with clinical evidence of inflammation.
Symptoms may include persistent nasal congestion, facial pressure, nasal discharge, and reduced sense of smell.
Not everyone with chronic sinusitis requires surgery. Many patients can be treated with appropriate medical management, including saline nasal irrigation, intranasal corticosteroids, and treatment of contributing conditions.
An ENT specialist may recommend further evaluation when symptoms remain troublesome despite appropriate treatment.
Endoscopic sinus surgery may be considered for selected patients based on their symptoms, nasal examination findings, imaging when indicated, and previous treatment history.
The aim is to improve access to affected sinus pathways, support drainage, and help manage ongoing disease. Surgery is not a guaranteed cure, and continued medical treatment may still be necessary.